Clinicians attending Monday afternoon’s “Best Practices in Hepatology 2018” Clinical Practice SIG Program will discover practical advice that will improve everyday patient care.
“The idea is to talk about things that are necessary for every practitioner, things that are common for every practitioner,” said Marcelo Kugelmas, MD, FAASLD, Director of Hepatology and Research, South Denver Gastroenterology, Denver, CO. “We want to share information that provides practical value about common things that we think about often.”
Dr. Kugelmas will co-chair the program, which takes place from 4:15 pm to 6:15 pm Monday in Room 24/25, with Kris V. Kowdley, MD, FAASLD, Director of the Liver Care Network and Organ Care Research at Swedish Medical Center, Seattle, WA. They will oversee four expert presentations:
Evaluation of the Incidentally Found Liver Mass: K. Rajender Reddy, MD, FAASLD, Professor of Medicine in the Division of Gastroenterology, University of Pennsylvania, will review the best steps to take when evaluating an incidentally found liver mass. Dr. Reddy will describe the best approaches based on the latest literature available and what clinicians are doing today in their practices.
Office-Based, Non-Invasive Assessment of Liver Fibrosis:Dr. Kugelmas will discuss how to make a practical assessment of liver fibrosis in the office and how that assessment affects choices made regarding selection and intensity of treatment along with post-treatment follow-up.
“There is a need for noninvasive means for assessment of liver fibrosis stage,” Dr. Kowdley said. “Liver biopsy is the established method, but is not accessible to many clinicians, unpopular with patients and may carry risks; however, assessment of liver fibrosis stage is an essential part of the evaluation of patients with liver disease; a review of office-based methods to stage liver fibrosis is very timely.”
Management of the Patient with Alcoholic Liver Disease (ALD): Craig J. McClain, MD, FAASLD, Professor of Medicine, University of Louisville School of Medicine, will review the research and advances in ALD. One of the research leaders in this field, Dr. McClain is the director of the Alcohol Research Center at Louisville.
“Alcoholic liver disease is like the unsung disease that everybody knows about and is quite relevant, but we talk a lot of about other diseases,” Dr. Kugelmas said. “But we all recognize we need to talk about alcoholic liver disease. There are advances and a lot of research.”
Care of the Post-Liver Transplant Patient in the Community Setting: Kirti Shetty, MD, Director of Hepatology at Sibley Memorial Hospital and Associate Professor of Medicine at Johns Hopkins University, will discuss the latest advancements and the possible pitfalls as the care of transplant patients continues to evolve.
“Whereas liver transplantation care used to be done solely at the big university centers, more and more patients are referred from private practice for liver transplantation and eventually returned to private practice care,” Dr. Kugelmas said.
The Liver Meeting® remains the premier event to present the latest liver-related research and cutting-edge science, but the majority of care takes place in office-based or in pure private practice settings. The program chairs noted that this Best Practices session is dedicated to giving practical advice for the day-to-day care based on both evidence-based recommendations and the opinions from some of the top liver care experts in the world.
“In terms of speakers, we try to include individuals who are experts in their field and represent the membership,” Dr. Kowdley said. “We want to include as speakers academicians and clinicians who represent the membership of the AASLD.”